Biopharma News
Sentry BioPharma's leadership is commited to continuing to evolve by developing services and expertise to address product integrity while meeting biopharmaceutical industry regulatory mandates. Sentry focuses on meeting and exceeding client and industry expectations and actively monitors developing biopharma news and issues, including product, business, and regulatory developments.
May 04, 2010 - Pharmaceutical Commerce Highlights Sentry BioPharma Services & Vetter Partnership
May 03, 2010 - Vetter and Sentry BioPharma Services establish preferred partnership agreement
Skokie, Ill., and Indianapolis, Ind., May 3, 2010 – Vetter, a leading provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, today announced that they have signed a preferred partnership agreement. Vetter will fill early-stage, high-value biopharmaceuticals at its Chicago facility; Sentry will label, package and ship the clinical supplies from its site in Indianapolis, Indiana. The collaboration will help streamline the path of study drugs from filling lab to clinic while safeguarding product integrity.
May 03, 2010 - Vetter und Sentry BioPharma Services vereinbaren Partnerschaft
Ravensburg/Indianapolis (USA), 3. Mai 2010 – Vetter, führender Anbieter aseptisch vorgefüllter Injektionssysteme, und Sentry BioPharma Services, Anbieter für klinische Supply-Chain-Dienstleistungen, Logistik und Verpackungen, haben eine Partnerschaftsvereinbarung unterzeichnet. Da Vetter in seinem US-Standort in Chicago hochwertige biopharmazeutische Wirkstoffe in frühen Entwicklungsphasen für klinische Prüfungen abfüllen wird und Sentry die Etikettierung, Verpackung und den Versand für klinische Studien in ihrem Werk in Indianapolis (USA) anbietet, schliesst diese Parterschaft die Lücke auf dem Weg des Produktes vom Abfülllabor zum klinischen Prüfungszentrum und sichert zugleich die notwendige Produktintegrität.
February 23, 2010 - Sentry BioPharma Services Awarded CDC Contract
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve.